12314 Effectiveness Of Continuous Glucose Monitors In Patients With Type 2 Diabetes On Washington Medicaid Or Financial Assistance

• DOI: 10.1210/jendso/bvae163.746
• Publication Date: 2024-10-05T20:58:51Z
• Authors: Alexandra Deng; Arthi Thirumalai; Jenny Lin; Marianne Weber; Silu Zuo

Abstract Disclosure: A. Deng: None. Thirumalai: J. Lin: M. Weber: S. Zuo: Continuous glucose monitors (CGMs) have become more accessible for patients with type 2 diabetes mellitus (T2DM) on one insulin injection per day who either commercial or Medicare plans. However, there are still strict requirements Washington State Medicaid, creating disparities in care vulnerable populations. The aim of this study is to assess the effectiveness and adherence CGMs T2DM Medicaid plans institutional financial assistance prescribed at least daily, similar requirements. This ongoing prospective cohort enrolled 40 adult T2DM, baseline A1C greater than 7%, from three Harborview Medical Center clinics. Through grant funding, were provided Freestyle Libre 6 months. Since an study, we present preliminary results completed 3 months CGM use. Effectiveness was measured by change after initiation (primary outcome) glycemic metrics ambulatory profile (AGP) (secondary outcomes). Assessment involved tracking percentage data captured AGP reports recorded each visit monitoring dispense history. Twenty reached 3-month follow-up a median age 59 years; 60% female, 70% non-English speaking; 45% 55% Financial Assistance as insurance coverage. Median 9.2%, duration 10 years, number medications 3, daily injections 2, blood checks 1. At first download (2 weeks), time range (TIR, 70-180 mg/dL) 53.5%, coefficient variation 35.3% percent 80%. follow-up, reduction A1c –1.2% (IQR -1.8, -0.5). On CGM, TIR had increased 60.5%, improved 31.5% 79%. In findings show encouraging early evidence control initiated sustained These should be interpreted caution given small participants Nonetheless, once complete, outcomes may used inform eligibility continuous Assistance. Presentation: 6/3/2024